BriaCell Therapeutics Corp. - Common Shares (BCTX)
5.0200
-0.5500 (-9.87%)
Briacell Therapeutics Corp is a biotechnology company focused on developing innovative immunotherapies to treat cancer, particularly breast cancer
The company specializes in creating personalized therapeutic approaches that harness the body’s immune system to target and eliminate cancer cells. Through its proprietary technology, Briacell aims to improve treatment outcomes for patients by enhancing the efficacy and safety of existing therapies, ultimately striving to bring new and effective cancer treatment options to the market. Their commitment to advancing cancer care is reflected in their rigorous research and clinical development efforts.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
SPONSORED CONTENT -- (StatePoint) As of January 2023, the number of women in the United States with a history of invasive breast cancer is estimated to be 3.1 million and is expected to increase by 12% to 4 million in 2024, according to the American Cancer Society.
BriaCell Therapeutics stock rises on positive Phase 2 trial results showing improved survival in late-stage metastatic breast cancer patients treated with Bria-IMT and an immune checkpoint inhibitor.
BriaCell Therapeutics Corp (NASDAQBCTX) reported preliminary survival and clinical benefit data in a new subset of advanced breast cancer patients treated with BriaCell's Bria-IMT regimen: patients that have developed resistance to (and failed to respond to)
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food and Drug Administration (FDA) granted several approvals and new Fast Track designations towards the end of 2022 […]
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs being labeled as landmark in nature and giving hope to families dealing with a fateful diagnosis. According to the American Cancer […]
